This Government Contract opportunity from The Judicial Branch was posted on June 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Urine Collection, Drug Testing, and Reporting

Closed

Federal

Submission Closed07/27/2026, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

Federal

DOT Controlled Substance and Alcohol Testing

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Reference Laboratory Testing Services

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Therapeutic Apheresis Service Provider

Network Contract Office 23 (36C263)

POSTED

DEADLINE

GEM-X Single Cell 5’ Gene Expression Kits and Companion Reagents.

Solicitation # 75N98026Q01198

The National Institutes of Health intends to award a firm-fixed-price purchase order to 10x Genomics for GEM-X Single Cell 5 prime Gene Expression Kits and companion reagents. This procurement includes specific quantities of Universal 5 prime Gene Expression v3 Kits, Chromium GEM-X Single Cell 5 prime Chip Kits v3, and Dual Index Kit TT Set A Kits. These materials are required to analyze gene expression profiles for approximately 96 individuals to identify risk factors and therapeutic targets for cardiometabolic diseases. The government is pursuing a sole-source procurement under FAR 6.302-1 because 10x Genomics is the sole manufacturer of these proprietary products, which are essential for maintaining compatibility with existing research workflows and previously collected data. While this is not a request for competitive quotations, interested parties may submit capability statements to the NIH by 9:00 a.m. EDT on September 21, 2026. The government expects to make an award approximately five calendar days after the closing date.

National Institutes Of Health Olao

POSTED

DEADLINE

Q301--VISN 22 Semen & Vasectomy Test Kits

Solicitation # 36C26226Q1411_1

Solicitation 36C26226Q1411 is a request for a single-award, firm-fixed-price Blanket Purchase Agreement to provide a comprehensive one-stop shop for Semen Analysis and Post Vasectomy Semen Analysis testing for the Department of Veterans Affairs VISN 22 healthcare centers. The contractor is responsible for providing FDA registered prepackaged mail-in kits for home self-collection, managing all logistics, and performing laboratory testing. The requirement includes the provision of all necessary supplies, such as temperature-controlled packaging with seasonal gel packs and non-toxic preservatives, ensuring specimens remain stable for at least 48 hours. The contract structure consists of a base year and four optional years, with annual estimated quantities of 1,104 Full Semen Analysis kits and 636 Post Vasectomy Semen Analysis kits. Notably, the contractor must provide up to two repeat PVSA tests at no additional cost. This procurement is a total small business set-aside under NAICS 62151//621511. The performing laboratory must maintain CLIA certification, although the previous requirement for CAP accreditation has been removed via amendment. Compliance with HIPAA, OSHA bloodborne pathogen standards, and DOT hazardous materials regulations for infectious substances is mandatory. Award will be granted to the responsible offeror who is technically acceptable and provides the lowest price. Following several amendments, the final response deadline for offers is September 18, 2026, at 07:00 Pacific Time.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Q301--VISN 22 Semen & Vasectomy Test Kits

Solicitation # 36C26226Q1411_

The Department of Veterans Affairs, through the Network Contract Office 22, is soliciting bids for the procurement of Semen and Vasectomy Test Kits under solicitation number 36C26226Q1411. This combined contract opportunity is designated as a total set-aside for small businesses and falls under NAICS code 621511. The response deadline for this requirement is September 8, 2026, at 2:00 PM. Interested parties should direct inquiries to the primary point of contact, Contract Specialist Marcos Diaz, regarding this procurement for the Gilbert, Arizona office.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Blood Draw, Drug, and Alcohol Testing Services

Solicitation # 200996

The City of Chattanooga Business Unit in Tennessee is seeking a provider for Blood Draw, Drug, and Alcohol Testing Services to support the Chattanooga Police Department. This solicitation, identified by number 200996, is for a four year agreement. The response deadline for this opportunity is September 16, 2026. Interested parties should coordinate with the buyer, Ariana Lynn Pazouki, regarding the submission of proposals for these medical testing services within the state of Tennessee.

City of Chattanooga Business Unit

POSTED

DEADLINE

Clinical Blood Processing and Diagnostic Testing

Defense Health Agency

POSTED

DEADLINE

Supply of BreathID Diagnostic Instrument

POSTED

DEADLINE

Anatomical Dissection and Serology Testing

POSTED

DEADLINE

Oncotype IQ Genomic Tests

Solicitation # 12468583-0001

The Defense Health Agency is conducting market research to identify qualified sources capable of providing the Oncotype IQ portfolio of genomic tests for the Walter Reed National Military Medical Center in Bethesda, Maryland. This Sources Sought notice is for planning purposes and is not a formal solicitation. The government is seeking capability statements from all interested parties, including large and small businesses under NAICS code 621511, to determine if there are sufficient qualified vendors to perform the work. Selected contractors will be responsible for providing all labor, materials, equipment, and transportation necessary for the genomic tests, with a requirement to deliver products within 10 days of receiving an order. Interested respondents must submit a detailed capability statement, including company identification and evidence of prior similar experience, via email to the designated points of contact by September 24, 2026. All correspondence must be handled through email, as phone calls and meetings are not permitted.

Defense Health Agency

POSTED

DEADLINE

BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan

Solicitation # HT941026Q2050

Solicitation HT941026Q2050 is a request for a five-year Blanket Purchase Agreement to provide medical reference laboratory testing services for the 18th Medical Group at Kadena Air Base, Japan. The scope of work includes providing all management, labor, and equipment for specific tests, including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The contractor must maintain current accreditation with the College of American Pathologists. While the original period of performance was slated for October 1, 2026, through September 30, 2031, subsequent amendments updated the period of performance to December 1, 2026, through November 30, 2031. The procurement is unrestricted and open for full and open competition under NAICS code 621511, although Amendment 5 removed the total small business set-aside clause. Award will be determined on a past performance price tradeoff basis, where past performance is considered more important than price. Technical capability will be rated as acceptable or unacceptable, and the government may accept a higher-priced quote if the quoter's past performance outweighs the price difference. Quotes must be submitted electronically to the Defense Health Agency Healthcare Contracting Division West by October 26, 2026.

Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in about 1 month

AI Contract Overview

The contract requires the provision of urine specimen collection, laboratory testing including urinalysis, and comprehensive reporting for drug monitoring services on a monthly basis. All procedures must adhere to strict chain-of-custody protocols and utilize bar-coded labels to ensure accurate tracking and compliance throughout the process. The work is to be performed for the Texas Eastern Probation Office-Tyler, operating under The Judicial Branch, with the primary place of performance located in Sherman. The solicitation was posted on June 24, 2026, with a response deadline of July 27, 2026, at 10:00 PM. Classified under NAICS code 621511, this is a subcontract opportunity and does not carry a specified set-aside designation. All deliverables must meet regulatory standards for forensic drug testing and reporting to support probationary oversight requirements.

General Info

Monthly urine testing and reporting for Texas Eastern Probation Office-Tyler with chain-of-custody and bar-coded tracking in Sherman.

Agency

The Judicial Branch → Texas Eastern Probation Office-TylerView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

Sherman, TX, USA

Set-Aside

NONE

Documents

This scope was carved out of 0540-27-0014.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

FY27 Treatment Services: Eastern District of Texas

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJun 24

subcontract

Response DeadlineJul 27

Deadline has passed

Submission Closed

07/27/2026, 10:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyThe Judicial Branch → Texas Eastern Probation Office-Tyler

ContactsNo contacts available

OfficeN/A

Organization / Agency

The Judicial Branch → Texas Eastern Probation Office-Tyler

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Perform urine specimen collection, laboratory testing (urinalysis), and reporting for drug monitoring with bar-coded labels and chain-of-custody compliance, required monthly.